Jason Pesile - 07 Mar 2023 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
Senior Vice President, Finance & Accounting.
Signature
/s/ Rene Paula Molina as Attorney-in-Fact for Jason Pesile
Issuer symbol
VAXX
Transactions as of
07 Mar 2023
Transactions value $
$0
Form type
4
Date filed
04 Apr 2023, 16:00
Previous filing
11 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAXX Stock Option (right to buy) Award $0 +32.7K $0.00 32.7K 07 Mar 2023 Class A Common Stock 32.7K $2.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023.

Remarks:

Senior Vice President, Finance & Accounting.